KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Non-Current Deffered Revenue (2017 - 2018)

Historic Non-Current Deffered Revenue for Co-Diagnostics (CODX) over the last 2 years, with Q3 2018 value amounting to $126066.0.

  • Co-Diagnostics' Non-Current Deffered Revenue fell 3227.5% to $126066.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $126066.0, marking a year-over-year decrease of 3227.5%. This contributed to the annual value of $183546.0 for FY2017, which is N/A changed from last year.
  • As of Q3 2018, Co-Diagnostics' Non-Current Deffered Revenue stood at $126066.0, which was down 3227.5% from $135762.0 recorded in Q2 2018.
  • Co-Diagnostics' 5-year Non-Current Deffered Revenue high stood at $188742.0 for Q2 2017, and its period low was $126066.0 during Q3 2018.